Financhill
Back

Arvinas Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
23

ARVN
Arvinas

Last Price:
24.82
Seasonality Move:
69.87%
Sell
40

EYPT
EyePoint Pharmaceuticals

Last Price:
8.01
Seasonality Move:
-9.25%
Sell
23
Arvinas (ARVN) is a Sell

Is Arvinas a Buy, Sell or Hold?

  • The current Arvinas [ARVN] share price is $24.83. The Score for ARVN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ARVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARVN Stock Price Chart

What is Arvinas's stock price today?

  • The Arvinas share price today is $24.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARVN is experiencing slight buying pressure.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 48.24 Sell
Chaikin Money Flow: 415065 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.47 - 25.65) Sell
Bollinger Bands (100): (24.13 - 30.43) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 42.06 Sell
Chaikin Money Flow: 232993 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.06 - 8.9) Sell
Bollinger Bands (100): (8.03 - 10.53) Sell

ARVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.6 Buy
20-day SMA: 24.87 Sell
50-day SMA: 25.6 Sell
200-day SMA: 33.97 Sell
8-day EMA: 24.68 Buy
20-day EMA: 24.91 Sell
50-day EMA: 25.76 Sell
200-day EMA: 29.69 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.22 Sell
20-day SMA: 8.42 Sell
50-day SMA: 8.66 Sell
200-day SMA: 15.98 Sell
8-day EMA: 8.2 Sell
20-day EMA: 8.4 Sell
50-day EMA: 8.83 Sell
200-day EMA: 12.03 Sell

Arvinas Earnings Growth & ARVN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Arvinas Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):